575 MADISON AVENUE, NEW YORK, NY
LB Pharmaceuticals Inc Enters Lease Amendment for Expansion Premises
Appoints Kaya Pai Panandiker as Chief Commercial Officer
Reports 3Q 2025 Financial Results and Recent Corporate Updates
News, Articles of Incorporation
Q3
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
Registration Statement for Securities to be Offered to Employees
Registration of Securities
Amended Registration Statement for Securities
S-1
No filings found
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
S-1MEF